InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Miller James Charles, Director. Director active across 2 companies, notably Recro Pharma, Inc.. In total, 4 disclosures have been published. Total volume traded: €5k. The latest transaction was filed on 18 March 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
87,500 shares
Common Stock
SEC:0001062993-22-013173:0·
€1,9331,000 shares@ €1.93250.0000% mcap100.0% of flow
Common Stock
SEC:0001062993-22-008331:0·
Ideal exit: 13 Dec 2022 (T+270)
€1,4921,000 shares@ €1.4915100.0% of flow
Common Stock
SEC:0000899243-21-045409·
Ideal exit: 14 Aug 2022 (T+270)
€1,4921,000 shares@ €1.491550.0% of flow
Common Stock
SEC:0000899243-21-045409:0·
Ideal exit: 14 Aug 2022 (T+270)
4 of 4 declarations
About Miller James Charles
James Charles Miller is a Board Member at Recro Pharma, Inc. and Societal CDMO, Inc. In this role, he oversees operations and contributes to the growth strategy of both companies. His expertise in the pharmaceutical sector is essential for their development.
